136 related articles for article (PubMed ID: 35704226)
1. Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer.
Corke L; Luzhna L; Willemsma K; Illmann C; Mcdermott M; Wilson C; Simmons C; LeVasseur N
Breast Cancer Res Treat; 2022 Aug; 194(3):587-595. PubMed ID: 35704226
[TBL] [Abstract][Full Text] [Related]
2. Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy.
Reis J; Boavida J; Tran HT; Lyngra M; Reitsma LC; Schandiz H; Melles WA; Gjesdal KI; Geisler J; Geitung JT
BMC Cancer; 2022 Jun; 22(1):702. PubMed ID: 35752785
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.
Abel MK; Greenwood H; Kelil T; Guo R; Brabham C; Hylton N; Wong J; Alvarado M; Ewing C; Esserman LJ; Boughey JC; Mukhtar RA
NPJ Breast Cancer; 2021 Mar; 7(1):25. PubMed ID: 33674614
[TBL] [Abstract][Full Text] [Related]
5. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
6. Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy?
Cortina CS; Gottschalk N; Kulkarni SA; Karst I
J Surg Res; 2021 Jan; 257():412-418. PubMed ID: 32892139
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survival.
Precht LM; Lowe KA; Atwood M; Beatty JD
Breast J; 2010; 16(4):362-8. PubMed ID: 20443786
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.
Hunt KK; Yi M; Mittendorf EA; Guerrero C; Babiera GV; Bedrosian I; Hwang RF; Kuerer HM; Ross MI; Meric-Bernstam F
Ann Surg; 2009 Oct; 250(4):558-66. PubMed ID: 19730235
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
LeVasseur N; Willemsma KA; Li H; Gondara L; Yip WC; Illmann C; Chia SK; Simmons C
Clin Breast Cancer; 2019 Dec; 19(6):e683-e689. PubMed ID: 31279611
[TBL] [Abstract][Full Text] [Related]
12. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
13. Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.
McGuire KP; Hwang ES; Cantor A; Golshan M; Meric-Bernstam F; Horton JK; Nanda R; Amos KD; Forero A; Hudis CA; Meszoely I; De Los Santos JF
Ann Surg Oncol; 2015 Jan; 22(1):75-81. PubMed ID: 25059792
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study.
Mattingly AE; Mooney B; Lin HY; Kiluk JV; Khakpour N; Hoover SJ; Laronga C; Lee MC
Clin Breast Cancer; 2017 Jun; 17(3):180-187. PubMed ID: 27956116
[TBL] [Abstract][Full Text] [Related]
15. The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
Fernandez-Gonzalez S; Falo C; Pla MJ; Pernas S; Bajen M; Soler T; Ortega R; Quetglas C; Perez-Martin X; Fernandez Montoli ME; Campos M; Varela-Rodriguez M; Ponce J; Garcia-Tejedor A
Clin Breast Cancer; 2018 Feb; 18(1):71-77. PubMed ID: 29030106
[TBL] [Abstract][Full Text] [Related]
16. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
17. The role of breast MRI in newly diagnosed breast cancer: An evidence-based review.
Thompson JL; Wright GP
Am J Surg; 2021 Mar; 221(3):525-528. PubMed ID: 33339617
[TBL] [Abstract][Full Text] [Related]
18. Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.
Garcia-Tejedor A; Falo C; Quetglas C; Soler T; Marqueta B; Ortega R; Gil-Gil M; Pernas S; Fernandez-Montolí E; Pla MJ; Guma A; Bajen M; Benitez A; Eraso A; Campos M; Petit A; Ponce J
Int J Surg; 2017 Mar; 39():141-147. PubMed ID: 28153783
[TBL] [Abstract][Full Text] [Related]
19. Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study.
Gonzalez V; Sandelin K; Karlsson A; Åberg W; Löfgren L; Iliescu G; Eriksson S; Arver B
World J Surg; 2014 Jul; 38(7):1685-93. PubMed ID: 24817517
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of response evaluation based on breast MRI after neoadjuvant treatment: a retrospective cohort study.
Bitencourt AGV; Pires BS; Calsavara VF; Negrão EMS; Souza JA; Graziano L; Guatelli CS; Makdissi FB; Sanches SM; Tavares MC; Osório CABT; De Brot M; Marques EF; Chojniak R
Eur Radiol; 2021 Dec; 31(12):9520-9528. PubMed ID: 34036420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
